Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. (SHE:300937)
China flag China · Delayed Price · Currency is CNY
34.12
+0.14 (0.41%)
At close: Feb 27, 2026

SHE:300937 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
3,2642,3943,0092,7614,358-
Market Cap Growth
43.48%-20.45%8.97%-36.64%--
Enterprise Value
3,2672,4062,9782,7284,281-
Last Close Price
34.1224.9331.0328.2944.66-
PE Ratio
-146.3250.5465.71680.87-
PS Ratio
0.740.550.680.701.28-
PB Ratio
3.982.813.523.375.53-
P/TBV Ratio
4.203.053.803.705.98-
P/FCF Ratio
-25.07-20.55--
P/OCF Ratio
-18.75-18.09--
EV/Sales Ratio
0.740.550.670.691.26-
EV/EBITDA Ratio
55.4249.7532.0135.22320.29-
EV/EBIT Ratio
112.3582.5240.2646.88117838.91-
EV/FCF Ratio
-71.1625.20-20.31--
Debt / Equity Ratio
0.460.460.390.300.170.08
Debt / EBITDA Ratio
6.386.603.352.977.810.55
Debt / FCF Ratio
-4.07-1.81-1.18
Net Debt / Equity Ratio
0.020.00-0.06-0.27-0.03-0.14
Net Debt / EBITDA Ratio
0.29-0.07-0.54-2.86-1.79-1.02
Net Debt / FCF Ratio
-0.31-0.040.33-1.650.13-2.18
Asset Turnover
2.462.572.702.863.363.53
Inventory Turnover
8.277.428.088.017.998.24
Quick Ratio
0.880.870.800.830.630.60
Current Ratio
1.511.651.721.682.202.04
Return on Equity (ROE)
-0.39%1.80%6.78%4.50%1.03%10.36%
Return on Assets (ROA)
1.02%1.07%2.82%2.62%0.00%4.94%
Return on Invested Capital (ROIC)
-1.12%3.16%8.56%6.88%0.01%12.40%
Return on Capital Employed (ROCE)
3.40%3.30%8.30%6.90%0.00%11.60%
Earnings Yield
-0.18%0.68%1.98%1.52%0.15%-
FCF Yield
-1.41%3.99%-5.01%4.87%-4.26%-
Dividend Yield
0.29%0.40%0.71%0.71%--
Payout Ratio
-184.93%40.51%12.63%322.93%23.40%
Buyback Yield / Dilution
-3.08%-0.21%-0.56%-4.44%-26.94%-0.24%
Total Shareholder Return
-2.78%0.19%0.15%-3.73%-26.94%-0.24%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.